Application no. and date | 09731866.1 (espacenet) (Federated) (European Patent Register), 20090415 | Patent/reg. no. and date | DK/EP 2279254, 20170705 | Publication date | 20110202 | Priority no. and date | US 45228 P, 20080415 | EP pub. no. and date |
EP 2279254 20110202 | Effective date | | Applicant/owner | Protiva Biotherapeutics Inc., 100-8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8, CA | Applicant ref. no. | P81703383DK00E | Inventor | MACLACHLAN, Ian, 8040 Aves Terrace
Mission, B.C. V4S 1E5, CA, YAWORSKI, Edward, 23106-123B Avenue
Maple Ridge, B.C. V2X 9Z7, CA, LAM, Kieu, 18871 71 Avenue
Surrey, B.C. V4N 5M7, CA, JEFFS, Lloyd B., 5218 Walnut Place
Delta, B.C. V4K 3B4, CA, PALMER, Lorne R., 8076 Elliott Street
Vancouver, B.C. V5S 2P2, CA | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/712 (2006.01) , A61K 31/713 (2006.01) , A61K 9/127 (2006.01) , A61P 35/00 (2006.01) , C12N 15/113 (2010.01) , C12N 15/88 (2006.01) | Title | HIDTIL UKENDTE LIPIDFORMULERINGER TIL NUKLEINSYREINDGIVELSE | Int. application no. | CA2009000496 | Int. publication no. | WO2009127060 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|